Intermediate-dose cytarabine or standard-dose cytarabine plus single-dose anthracycline as post-remission therapy in older patients with acute myeloid leukemia: impact on health care resource consumption and outcomes

Detalles Bibliográficos
Autores principales: Galtier, Jean, Alric, Camille, Bérard, Emilie, Leguay, Thibaut, Tavitian, Suzanne, Bidet, Audrey, Delabesse, Eric, Rieu, Jean Baptiste, Vial, Jean-Philippe, Vergez, François, Lechevalier, Nicolas, Luquet, Isabelle, Klein, Emilie, de Grande, Anne-Charlotte, Sarry, Audrey, Pigneux, Arnaud, Récher, Christian, Bertoli, Sarah, Dumas, Pierre-Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590686/
https://www.ncbi.nlm.nih.gov/pubmed/34775463
http://dx.doi.org/10.1038/s41408-021-00551-y
Descripción
Sumario:

Ejemplares similares